Anika Therapeutics is the first major Life Sciences commission led by Michele Brooks. The project signals the next generation of OL+ Life Sciences work, building on the foundation laid by Randy Lewis at Harvard, Millennium, and the Broad Institute. The Anika relationship will continue into the 2010s with an Italy commission, an early signal that the practice has grown beyond New England.